Nanomaterials in gene therapy and genome editing: challenges and emerging directions
Mingyang Jiang, Ke Zhang, Zheng Wang, Ming Gao, Shanggui Su, Junjun He, Huihui Xu, Zhandong Bo, Zhenqi Jiang, Chengcheng Zhang, James HP Hui, Ruqiong Wei · 2025
Read Nanomaterials in gene therapy and genome editing: challenges and emerging directions by Mingyang Jiang, Ke Zhang, Zheng Wang, Ming Gao, Shanggui Su, Junjun He, Huihui Xu, Zhandong Bo, Zhenqi Jiang, Chengcheng Zhang, James HP Hui, Ruqiong Wei (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12822215.txt.
Description
Tiny engineered carriers can ferry gene editing tools into the body, but getting them to the clinic is the hard part, argues a 2025 review by Mingyang Jiang and co-authors. Lipid, polymer, and inorganic carriers each cross body barriers in their own way, and each misbehaves in its own way too.
The review weighs off target editing, immune reactions, and uneven spread through the body against the gains in delivery. It highlights fine tuned lipid particles that escape cell compartments well, then turns to scale up, long term safety, and rules. The authors call for shared tests that link a carrier's design to what it does in patients.
Catalog record
| CREATOR | Mingyang Jiang, Ke Zhang, Zheng Wang, Ming Gao, Shanggui Su, Junjun He, Huihui Xu, Zhandong Bo, Zhenqi Jiang, Chengcheng Zhang, James HP Hui, Ruqiong Wei |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 95 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |